Post-effective amendment to a registration statement that is not immediately effective upon filing

SHARE-BASED COMPENSATION (Details 1)

v3.23.1
SHARE-BASED COMPENSATION (Details 1) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Total share-based compensation $ 1,939 $ 6,564 $ 21,130 $ 10,577
Intrinsic value of options 0      
Intrinsic value of vested/exercisable options $ 0      
Stock Options [Member]        
Number of Shares Options Outstanding, Beginning 7,812,178 [1] 5,489,492 5,489,492  
Exercise Price Outstanding, Beginning $ 3.70 [1] $ 4.23 $ 4.23  
Weighted Average Remaining Contractual Life (Years) 6 years 3 months 25 days [2]   6 years 6 months 21 days  
Weighted-Average Grant Date Fair Value,Beginning $ 2.23 [1] $ 2.27 $ 2.27  
Number of Shares Options, Forfeited (31,523)   (65,634)  
Exercise Price Forfeited $ 2.26   $ 4.50  
Weighted-Average Grant Date Fair Value,Forfeited $ 1.46   2.52  
Number of Shares Options Expired (14,421)      
Exercise Price Expired $ 5.40      
Weighted-Average Grant Date Fair Value,Expired $ 2.86   $ 2.82  
Number of Shares Options Outstanding, Ending 7,766,234 [2]   7,812,178 [1] 5,489,492
Exercise Price Outstanding, Ending $ 3.70 [2]   $ 3.70 [1] $ 4.23
Weighted-Average Grant Date Fair Value,Ending $ 1.98 [2]   $ 2.23 [1] $ 2.27
Exercisable 4,870,164 [3]   4,525,905 [4]  
Exercise Price Outstanding, Ending [3] $ 4.03      
Weighted Average Remaining Contractual Life (Years) exercisable 4 years 10 months 13 days [3]   4 years 10 months 2 days [4]  
Weighted-average grant date fair value exercisable [3] $ 2.12      
Research and Development Expense [Member]        
Total share-based compensation $ 531 $ 966 $ 3,554 $ 1,812
Selling and Marketing Expense [Member]        
Total share-based compensation 507 1,083 3,491 6,759
General and Administrative Expense [Member]        
Total share-based compensation 894 4,474 13,842 1,925
Cost of Sales [Member]        
Total share-based compensation $ 7 $ 41 $ 243 $ 81
[1] There was no aggregate intrinsic value of all stock options outstanding as of December 31, 2022.
[2] There was no aggregate intrinsic value of all stock options outstanding as of March 31, 2023.
[3] There was no aggregate intrinsic value of all vested/exercisable stock options as of March 31, 2023.
[4] There was no aggregate intrinsic value of all vested/exercisable stock options as of December 31, 2022.